PMC:7306567 / 2318-3045
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T3 | 146-156 | Body_part | denotes | neutrophil | http://purl.org/sig/ont/fma/fma62860 |
| T4 | 172-176 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T5 | 466-470 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 53 | 516-541 | Disease | denotes | graft-versus-host disease | MESH:D006086 |
| 46 | 710-719 | Chemical | denotes | ibrutinib | MESH:C551803 |
| 47 | 0-32 | Disease | denotes | Invasive pulmonary aspergillosis | MESH:D055744 |
| 48 | 113-134 | Disease | denotes | prolonged neutropenia | MESH:D009503 |
| 49 | 146-184 | Disease | denotes | neutrophil disorders or T cell defects | MESH:C563515 |
| 50 | 338-360 | Disease | denotes | invasive aspergillosis | MESH:D055744 |
| 51 | 418-432 | Disease | denotes | acute leukemia | MESH:D015470 |
| 52 | 434-436 | Disease | denotes | AL | MESH:D009101 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T21 | 19-32 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
| T22 | 123-134 | Disease | denotes | neutropenia | http://purl.obolibrary.org/obo/MONDO_0001475 |
| T23 | 338-360 | Disease | denotes | invasive aspergillosis | http://purl.obolibrary.org/obo/MONDO_0000240 |
| T24 | 347-360 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
| T25 | 362-364 | Disease | denotes | IA | http://purl.obolibrary.org/obo/MONDO_0000240 |
| T26 | 418-432 | Disease | denotes | acute leukemia | http://purl.obolibrary.org/obo/MONDO_0010643 |
| T27 | 424-432 | Disease | denotes | leukemia | http://purl.obolibrary.org/obo/MONDO_0005059 |
| T28 | 434-436 | Disease | denotes | AL | http://purl.obolibrary.org/obo/MONDO_0010643 |
| T29 | 516-541 | Disease | denotes | graft-versus-host disease | http://purl.obolibrary.org/obo/MONDO_0013730 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 42-43 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T16 | 170-176 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
| T17 | 466-470 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T18 | 721-725 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 4, 5 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T4 | 34-37 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
| T6 | 362-364 | Chemical | denotes | IA | http://purl.obolibrary.org/obo/CHEBI_74062 |
| T7 | 434-436 | Chemical | denotes | AL | http://purl.obolibrary.org/obo/CHEBI_73770 |
| T8 | 552-562 | Chemical | denotes | antifungal | http://purl.obolibrary.org/obo/CHEBI_35718 |
| T9 | 710-719 | Chemical | denotes | ibrutinib | http://purl.obolibrary.org/obo/CHEBI_76612 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T6 | 0-32 | Phenotype | denotes | Invasive pulmonary aspergillosis | http://purl.obolibrary.org/obo/HP_0020103 |
| T7 | 34-37 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
| T8 | 123-134 | Phenotype | denotes | neutropenia | http://purl.obolibrary.org/obo/HP_0001875 |
| T9 | 418-432 | Phenotype | denotes | acute leukemia | http://purl.obolibrary.org/obo/HP_0002488 |
| T10 | 434-436 | Phenotype | denotes | AL | http://purl.obolibrary.org/obo/HP_0002488 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T20 | 0-305 | Sentence | denotes | Invasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. |
| T21 | 306-607 | Sentence | denotes | Patients at the highest risk of invasive aspergillosis (IA) include those undergoing intensive chemotherapy for acute leukemia (AL) or recipients of allogeneic cell transplantation (alloHCT) who develop severe graft-versus-host disease, for whom antifungal prophylaxis is currently recommended [2, 3]. |
| T22 | 608-727 | Sentence | denotes | With changing treatment modalities, new risk groups continue to emerge, such as patients treated with ibrutinib [4, 5]. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 9-18 | UBERON:0002048 | denotes | pulmonary |
| T30 | 96-107 | NCBITaxon:1 | denotes | individuals |
| T31 | 146-156 | CL:0000775 | denotes | neutrophil |
| T32 | 170-176 | CL:0000084 | denotes | T cell |
| T33 | 275-292 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
| T34 | 710-719 | CHEBI:76612;CHEBI:76612 | denotes | ibrutinib |
| T81322 | 9-18 | UBERON:0002048 | denotes | pulmonary |
| T51311 | 96-107 | NCBITaxon:1 | denotes | individuals |
| T81106 | 146-156 | CL:0000775 | denotes | neutrophil |
| T17383 | 170-176 | CL:0000084 | denotes | T cell |
| T96288 | 275-292 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
| T80755 | 710-719 | CHEBI:76612;CHEBI:76612 | denotes | ibrutinib |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32572532-25354514-47963394 | 302-303 | 25354514 | denotes | 1 |
| 32572532-29437588-47963395 | 721-722 | 29437588 | denotes | 4 |
| T48775 | 302-303 | 25354514 | denotes | 1 |
| T15892 | 721-722 | 29437588 | denotes | 4 |